Ascendis Pharma A/S (ASND)
205.70
-4.75
(-2.26%)
USD |
NASDAQ |
Jun 08, 16:00
205.82
+0.12
(+0.06%)
After-Hours: 19:29
Ascendis Pharma Market Cap : 12.78B for June 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Evaxion AS | 31.19M |
| DBV Technologies SA | 949.89M |
| Genmab A/S | 15.22B |
| Cellectis SA | 295.77M |
| Akari Therapeutics Plc | 17.95M |
Market Cap Related Metrics
| PE Ratio | 23.18 |
| PS Ratio | 12.64 |
| Price to Book Value | 22.72 |
| Price to Free Cash Flow | 251.30 |
| Price | 205.70 |
| Earnings Yield | 4.31% |
| Normalized PE Ratio | 23.18 |